Citation Tools
PDFPsoriatic arthritis
Original research
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials